JP2025067915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025067915A5 JP2025067915A5 JP2025006393A JP2025006393A JP2025067915A5 JP 2025067915 A5 JP2025067915 A5 JP 2025067915A5 JP 2025006393 A JP2025006393 A JP 2025006393A JP 2025006393 A JP2025006393 A JP 2025006393A JP 2025067915 A5 JP2025067915 A5 JP 2025067915A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- antibody
- asc
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/026,482 US10703811B2 (en) | 2016-12-29 | 2018-07-03 | Methods and compositions for treating multiple sclerosis |
| US16/026,482 | 2018-07-03 | ||
| JP2020573110A JP2021528092A (ja) | 2018-07-03 | 2019-07-03 | インフラマソームに関連する疾患又は病態を治療するための組成物及び方法 |
| PCT/US2019/040635 WO2020010273A1 (en) | 2018-07-03 | 2019-07-03 | Compositions and methods for treating inflammasome related diseases or conditions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573110A Division JP2021528092A (ja) | 2018-07-03 | 2019-07-03 | インフラマソームに関連する疾患又は病態を治療するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025067915A JP2025067915A (ja) | 2025-04-24 |
| JP2025067915A5 true JP2025067915A5 (enExample) | 2025-05-21 |
Family
ID=78823964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573110A Pending JP2021528092A (ja) | 2018-07-03 | 2019-07-03 | インフラマソームに関連する疾患又は病態を治療するための組成物及び方法 |
| JP2025006393A Pending JP2025067915A (ja) | 2018-07-03 | 2025-01-16 | インフラマソームに関連する疾患又は病態を治療するための組成物及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573110A Pending JP2021528092A (ja) | 2018-07-03 | 2019-07-03 | インフラマソームに関連する疾患又は病態を治療するための組成物及び方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210284723A1 (enExample) |
| EP (1) | EP3818081A4 (enExample) |
| JP (2) | JP2021528092A (enExample) |
| KR (1) | KR20210071944A (enExample) |
| CN (1) | CN113316588B (enExample) |
| AU (1) | AU2019297515A1 (enExample) |
| BR (1) | BR112020026798A2 (enExample) |
| CA (1) | CA3105129A1 (enExample) |
| CL (1) | CL2020003447A1 (enExample) |
| CO (1) | CO2021001172A2 (enExample) |
| IL (1) | IL279851A (enExample) |
| MX (1) | MX2021000142A (enExample) |
| PH (1) | PH12020552286A1 (enExample) |
| SG (1) | SG11202013176VA (enExample) |
| WO (1) | WO2020010273A1 (enExample) |
| ZA (2) | ZA202100703B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021222263A2 (en) * | 2020-04-27 | 2021-11-04 | University Of Miami | Compositions and methods for treating inflammasome related diseases or conditions |
| US11840565B2 (en) | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
| WO2018126009A1 (en) | 2016-12-29 | 2018-07-05 | University Of Miami | Method for modulating inflammasome activity and inflammation in the lung |
| JP2024544997A (ja) * | 2021-11-16 | 2024-12-05 | エイシー イミューン ソシエテ アノニム | 治療および診断のための新規分子 |
| CA3267095A1 (en) * | 2022-09-09 | 2024-03-14 | University Of Miami | Composition of anti-inflammatory antibodies and method of treating a neurological disorder |
| WO2024114906A1 (en) * | 2022-11-30 | 2024-06-06 | Mabylon Ag | Antibodies against apoptosis-associated speck-like protein containing a card (asc) and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018194A1 (en) * | 2000-11-28 | 2004-01-29 | Francisco Joseph A. | Recombinant anti-CD30 antibodies and uses thereof |
| WO2005111283A1 (ja) * | 2004-05-17 | 2005-11-24 | Denki Kagaku Kogyo Kabushiki Kaisha | ポリ塩化ビニル繊維及びその製造方法並びに人工毛髪 |
| NZ554725A (en) * | 2004-10-25 | 2009-10-30 | Merck & Co Inc | Anti-ADDL antibodies and uses thereof |
| TW200636064A (en) * | 2004-10-28 | 2006-10-16 | Centocor Inc | Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| RU2009135824A (ru) * | 2007-02-27 | 2011-04-10 | Дженентек, Инк. (Us) | Антитела-антагонисты против ох40 и их применение в лечении воспалительных и аутоиммунных заболеваний |
| US8685400B2 (en) * | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| WO2010003092A1 (en) * | 2008-07-03 | 2010-01-07 | University Of Massachusetts | Methods and compositions for reducing inflammation and treating inflammatory disorders |
| SMT202000095T1 (it) * | 2010-05-14 | 2020-03-13 | Amgen Inc | Formulazioni di anticorpi anti-sclerostina ad alta concentrazione |
| JP5976695B2 (ja) * | 2011-03-11 | 2016-08-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 慢性閉塞性肺疾患（ｃｏｐｄ）のマーカーとしてのａｓｃ |
| US20140314746A1 (en) * | 2013-03-13 | 2014-10-23 | Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine | Methods for treating or preventing fibrosis in subjects afflicted with scleroderma |
| WO2015016178A1 (ja) * | 2013-07-29 | 2015-02-05 | 国立大学法人鹿児島大学 | １，５－ｄ－アンヒドロフルクトースを含むアポトーシス関連スペック様カード蛋白質の機能阻害薬 |
| KR101948048B1 (ko) * | 2016-12-08 | 2019-02-14 | 한양대학교 에리카산학협력단 | 톡소포자충 ｇｒａ７ 항원 유래 재조합 단백질을 유효성분으로 포함하는 결핵 예방 또는 치료용 약학 조성물 |
| US11840565B2 (en) * | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
| WO2018126009A1 (en) * | 2016-12-29 | 2018-07-05 | University Of Miami | Method for modulating inflammasome activity and inflammation in the lung |
-
2019
- 2019-07-03 CN CN201980056542.1A patent/CN113316588B/zh active Active
- 2019-07-03 US US17/255,653 patent/US20210284723A1/en active Pending
- 2019-07-03 MX MX2021000142A patent/MX2021000142A/es unknown
- 2019-07-03 BR BR112020026798-8A patent/BR112020026798A2/pt unknown
- 2019-07-03 CA CA3105129A patent/CA3105129A1/en active Pending
- 2019-07-03 WO PCT/US2019/040635 patent/WO2020010273A1/en not_active Ceased
- 2019-07-03 AU AU2019297515A patent/AU2019297515A1/en active Pending
- 2019-07-03 SG SG11202013176VA patent/SG11202013176VA/en unknown
- 2019-07-03 JP JP2020573110A patent/JP2021528092A/ja active Pending
- 2019-07-03 KR KR1020217003239A patent/KR20210071944A/ko active Pending
- 2019-07-03 EP EP19831331.4A patent/EP3818081A4/en active Pending
-
2020
- 2020-12-29 PH PH12020552286A patent/PH12020552286A1/en unknown
- 2020-12-30 CL CL2020003447A patent/CL2020003447A1/es unknown
- 2020-12-30 IL IL279851A patent/IL279851A/en unknown
-
2021
- 2021-02-01 ZA ZA2021/00703A patent/ZA202100703B/en unknown
- 2021-02-02 CO CONC2021/0001172A patent/CO2021001172A2/es unknown
-
2022
- 2022-01-31 ZA ZA2022/01437A patent/ZA202201437B/en unknown
-
2025
- 2025-01-16 JP JP2025006393A patent/JP2025067915A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024109678A5 (enExample) | ||
| JP2025067915A5 (enExample) | ||
| JP2024038003A5 (enExample) | ||
| JP2025065427A5 (enExample) | ||
| JP2023002562A5 (enExample) | ||
| JP2022191383A5 (enExample) | ||
| JP2022106952A5 (enExample) | ||
| JP2022177090A5 (enExample) | ||
| JP2023093753A5 (enExample) | ||
| CN112135626A (zh) | 抗tigit抗体及其用途 | |
| JP2024024114A5 (enExample) | ||
| CN115605511A (zh) | 抗tigit的抗体、其制备方法和应用 | |
| RU2020130795A (ru) | Нейтрализующие антитела к env вич-1 и их применение | |
| JP2011527899A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2020515277A5 (enExample) | ||
| JPWO2020004490A5 (enExample) | ||
| CN117551200A (zh) | 一种抗人cd45抗体或其抗原结合片段及其制备方法 | |
| JPWO2022256563A5 (enExample) | ||
| JP2025063187A5 (enExample) | ||
| JPWO2022173670A5 (enExample) | ||
| JPWO2019177854A5 (enExample) | ||
| CN114605532B (zh) | 抗β-淀粉样蛋白抗体及其用途 | |
| JPWO2022079139A5 (enExample) | ||
| JPWO2023129928A5 (enExample) |